Company intelligence / Profile preview

MedSource

Houston, Texas, United Statesmedsourcellc.com ↗

Ownership: Private
Employees: ~110
Development stage: Commercial

Overview

MedSource was a full-service contract research organization (CRO) specializing in complex clinical trials for oncology and rare diseases. It participated in over 200 oncology and rare disease trials before being acquired by Ergomed in December 2020. The company was recognized for its expertise in high-quality trial execution and strong client relationships, with an order book exceeding $41 million at the time of acquisition.

Therapeutic areas: OncologyRare DiseasesCardiovascularNeurologyInfectious Diseases
Industry: Contract Research Organization

Partnerships

Eli LillyBaylor College of Medicine

Beyond the preview

Go deeper on MedSource.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedSource.

Explore the full profile